Replies to post #34448 on EVIO Inc (EVIO)

[Investor_2016]

The key question is whether the R/S will help attract conventional financing. Does the stock being on NASDAQ help accomplish that? If it does, then it seems like a win.

[Preserve]

i dont believe its a p&d: its simply terribbly mismanaged - ive seen references to the CEO bio thta he built a chain of foto-mats or something 20 years ago - the problem is - it wasnt a public company -

The management appears to be utterly clueless in operating a public company. The 4x dilution in the past 18 months. The late filings again and again. The constant stream of dilutive notes (this is especially galling since there has been over 500 million equity dollars announced in 2017 so far as flowing into public cannabis deals, yet all Signal Bay can find is convertible debt notes from the most predatory lenders trolling the muck of the pinks.

So. if we agree , its apparently not a p&d. Yet the companies only funding options are from the same lenders propping up toxic p&d deals. What gives?

My guess is management can impress enough of the dim bulbs buying a penny stock. And a few, likely high on pot, lab owners, to come along for the ride. But management cant get the confidence of the institutional money.

This announced roll back is way late. Lets hope that the mess the stock structure is the only management infrastructure issue. If the management team cant get the support of anyone but the toxic note sludge. theres trouble.

I think management knows it and its why there is the takeover provision in the minutes of that announced shareholder meeting. The abusive and wanton manner that management took in funding the company diluted the stock 4x in 18 months - The ridiculous conversion rates and the subsequent dumping of the stock every 90 days like clockwork has destryed the stock price, but i think the ability of the principals to even retain a 50% control of the overall stock is in question.